Literature DB >> 3519678

Multiple biological activities of human recombinant interleukin 1.

C A Dinarello, J G Cannon, J W Mier, H A Bernheim, G LoPreste, D L Lynn, R N Love, A C Webb, P E Auron, R C Reuben.   

Abstract

Complementary DNA coding for human monocyte interleukin 1 (IL-1), pI 7 form, was expressed in Escherichia coli. During purification, IL-1 activity on murine T cells was associated with the recombinant protein. Homogeneous human recombinant IL-1 (hrIL-1) was tested in several assays to demonstrate the immunological and inflammatory properties attributed to this molecule. hrIL-1 induced proliferative responses in a cloned murine T cell in the presence of suboptimal concentrations of mitogen, whereas no effect was observed with hrIL-1 alone. At concentrations of 0.05 ng/ml, hrIL-1 doubled the response to mitogen (5 X 10(6) half maximal units/mg). Human peripheral blood T cells depleted of adherent cells underwent a blastogenic response and released interleukin 2 in the presence of hrIL-1 and mitogen. hrIL-1 was a potent inflammatory agent by its ability to induce human dermal fibroblast prostaglandin E2 production in vitro and to produce monophasic (endogenous pyrogen) fever when injected into rabbits or endotoxin-resistant mice. These studies establish that the dominant pI 7 form of recombinant human IL-1 possesses immunological and inflammatory properties and acts on the central nervous system to produce fever.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519678      PMCID: PMC370527          DOI: 10.1172/JCI112495

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

2.  Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.

Authors:  P A Murphy; P L Simon; W F Willoughby
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

3.  The macrophage as an effector cell.

Authors:  C F Nathan; H W Murray; Z A Cohn
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

4.  Effect of human monocyte pyrogen on plasma iron, plasma zinc, and blood neutrophils in rabbits and rats.

Authors:  R F Kampschmidt; L A Pulliam
Journal:  Proc Soc Exp Biol Med       Date:  1978-05

5.  Studies on the active site of human leukocytic pyrogen.

Authors:  C A Dinarello; K Bendtzen; S M Wolff
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

6.  Intracellular human IL-1: a precursor for the secreted monokine.

Authors:  C G Sahasrabuddhe; C Dinarello; B Martin; A L Maizel
Journal:  Lymphokine Res       Date:  1985

7.  A new sensitive method for detecting human endogenous (leukocyte) pyrogen.

Authors:  P Bodel; H Miller
Journal:  Inflammation       Date:  1978-03       Impact factor: 4.092

8.  Heterogeneity of rabbit endogenous pyrogens is not attributable to glycosylated variants of a single polypeptide chain.

Authors:  P A Murphy; T A Cebula; B E Windle
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

9.  Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen.

Authors:  L J Rosenwasser; C A Dinarello; A S Rosenthal
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

10.  Demonstration and characterization of two distinct human leukocytic pyrogens.

Authors:  C A Dinarello; N P Goldin; S M Wolff
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  65 in total

Review 1.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  Effects of IL-1 muteins on cartilage degradation and as inducers of acute inflammation.

Authors:  M A Pratta; E C Arner; B L Rule; W Galbraith
Journal:  Agents Actions       Date:  1991-09

3.  NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.

Authors:  Florian R Greten; Melek C Arkan; Julia Bollrath; Li-Chung Hsu; Jason Goode; Cornelius Miething; Serkan I Göktuna; Michael Neuenhahn; Joshua Fierer; Stephan Paxian; Nico Van Rooijen; Yajun Xu; Timothy O'Cain; Bruce B Jaffee; Dirk H Busch; Justus Duyster; Roland M Schmid; Lars Eckmann; Michael Karin
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

4.  Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Authors:  J W Mier; G Vachino; J W van der Meer; R P Numerof; S Adams; J G Cannon; H A Bernheim; M B Atkins; D R Parkinson; C A Dinarello
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

5.  Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6.

Authors:  D Habetswallner; E Pelosi; D Bulgarini; A Camagna; P Samoggia; E Montesoro; G Giannella; D Lazzaro; G Isacchi; U Testa
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

6.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

7.  Interleukin 1 administration in mice produces hypoferremia despite neutropenia.

Authors:  V R Gordeuk; P Prithviraj; T Dolinar; G M Brittenham
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitution.

Authors:  Janice P Dutcher; Donna Neuberg; Michael B Atkins; William J Tester; Scott Wadler; James A Stewart; Abraham Chachoua; Lynn M Schuchter
Journal:  J Interferon Cytokine Res       Date:  2014-01-16       Impact factor: 2.607

9.  Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation.

Authors:  Monica Guma; Lisa Ronacher; Ru Liu-Bryan; Shinji Takai; Michael Karin; Maripat Corr
Journal:  Arthritis Rheum       Date:  2009-12

10.  Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis.

Authors:  Christian Stehlik
Journal:  Arthritis Rheum       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.